CyGenica

About:

CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs and antibiotics.

Website: https://www.cygenica.com/

Twitter/X: cycaoncosol/

Top Investors: SOSV, Golden Sparrow Ventures, VOYAGERS Health-Tech Fund, David Rowan, Sharaf Yamani

Description:

CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.

Total Funding Amount:

$1.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pune, Maharashtra, India

Founded Date:

2017-01-01

Contact Email:

info(AT)cygenica.com

Founders:

Nusrat Jahan Sanghamitra

Number of Employees:

1-10

Last Funding Date:

2021-06-08

IPO Status:

Private

Industries: